A great deal is understood about NF1 and the cellular and molecular effects of the absence of neurofibromin and there is exciting development of therapies for NF1-associated tumors such as pNF and optic pathway gliomas.12,13 However, relatively little is known about cNF. The gene discussed is NF1; the disease is optic pathway glioma.